ORIC PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$9.24
+2.78%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-26.2%
3 months
-12.8%
6 months
-5.4%
1 year
-30.7%
Year to date
+13.0%
52-week range
$7.48 – $14.65
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$957.8M
P/E
-6.8
P/B
2.5
P/S
—
Revenue
$0
Net income
-$140.35M
Diluted EPS
-1.32
Gross margin
—
Net margin
—
Return on equity
-35.40%
Total debt
$0
Cash
$37.48M
Free cash flow
-$112.26M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$41.49M | — | — | -$31.96M |
| Mar 31, 2026 | $0 | -$35.77M | — | — | -$32.44M |
| Dec 31, 2025 | $0 | -$30.51M | — | — | -$22.71M |
| Sep 30, 2025 | $0 | -$32.59M | — | — | -$25.15M |
| Jun 30, 2025 | $0 | -$36.36M | — | — | -$30.91M |
| Mar 31, 2025 | $0 | -$30.02M | — | — | -$32.92M |
| Dec 31, 2024 | $0 | -$36.31M | — | — | -$28.27M |
| Sep 30, 2024 | $0 | -$34.57M | — | — | -$29.22M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ORIC news
All market newsNo ticker-linked stories are in the current archive.